Recombinant Virus Like Particles as Drug Delivery System

Author(s): Christiane Georgens , Jorg Weyermann , Andreas Zimmer .

Journal Name: Current Pharmaceutical Biotechnology

Volume 6 , Issue 1 , 2005

Become EABM
Become Reviewer

Abstract:

The drug delivery system described here is based on a virus like particle consisting of the recombinant expressed major capsid protein of Polyomavirus, VP1. Polyoma, a murine virus belonging to the Papovaviridae, forms a non-enveloped icosahedral capsid. These capsids are organized as a double shell composed of three different proteins: VP1,VP2 and VP3. The outer shell of the vision is composed of 360 VP1 molecules arranged as 72 pentamers. These capsids have a diameter of about 50 nm. The VP1 protein acts as a major ligand for certain membrane receptors during virus infection. Furthermore, the N-terminus of the VP1 protein contains a DNA-binding domain and a nuclear localization sequence. The recombinant production of the VP1 protein offers a save way to obtain a highly purified, non-pathogenic pharmaceutical excipient. Combining these aspects, VP1 proteins provide a targeting as well as a drug binding site when used as a save drug carrier for gene therapy. Current applications are also including oligonucleotides as well as small molecules as well as vaccines.

Keywords: artificial virus, virus like particle, vp1 capsids, drug delivery system

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 6
ISSUE: 1
Year: 2005
Page: [49 - 55]
Pages: 7
DOI: 10.2174/1389201053167202

Article Metrics

PDF: 32